eBook
Primary Risks That Threatened the Pharmaceutical Sector During the COVID-19 Pandemic
At the height of the COVID-19 outbreak, many industries struggled to adapt to the operational changes and challenges brought about by the pandemic. The Pharmaceutical industry on the other hand quickly sprang into action. While the sector was able to deliver diagnostic testing and vaccines at incredible speed, the pandemic exposed how vulnerable the sector is to risks.
Download this ebook to learn:
- How the pandemic exposed the pharma sector to increased cyber and supply chain vulnerabilities
- How misinformation and conspiracy theories can negatively affect pharmaceutical companies’ reputation
- How real-time data can help mitigate and manage risks to people and assets
Download your free copy by completing the short form on the right.
Get the ebook
Related resources
Infographic
COVID 19: Continuous Coverage of a Developing Outbreak
Dataminr alerted clients to the presence of COVID-19 in Wuhan, China 7 days before the first announcement from the U.S. government, and weeks before the virus began dominating major media outlets.
Report
Dataminr COVID-19 U.S. County Study
COVID-19 eyewitness public social media clusters can provide advance warning of virus outbreak hotspots and suggest an impending case spike in 22 U.S. counties across eight U.S. states.
Blog
Adopting a Holistic Approach to Security Operations in a Post-COVID World
As security officers look ahead to a post-pandemic future, many find themselves with expanded budgets and an executive mandate to build the systems necessary to respond to the next global risk incident. But how?